Orlistat mouth rinse effectively lowers total and fat calorie intake in obese individuals

Written By :  Jacinthlyn Sylvia
Medically Reviewed By :  Dr. Kamal Kant Kohli
Published On 2023-05-23 04:30 GMT   |   Update On 2023-10-26 11:39 GMT
Advertisement

A new study published in the Journal of Diabetes Obesity and Metabolism found that, Orlistat mouth rinse may be an effective alternative in lowering calorie intake while minimizing undesirable side effects in Obese people.

Orlistat belongs to a family of medications known as anti-obesity treatments, which are used to treat obesity and greatly help in weight loss. Orlistat should always be used in conjunction with a low-calorie diet and frequent physical activity. Obesity is a prevalent disorder characterized by excess body fat, which raises the risk of numerous health issues such as diabetes, high blood pressure, some malignancies, and heart disease. As a result, the team led by Stefany Primeaux undertook this study to completely explore the effects of an orlistat mouth rinse on the consumption of a high-fat meal.

Advertisement

In this double-blind, balanced order, crossover study, the participants (n = 10, body mass index 25-30 kg/m2) were randomized to consume placebo or orlistat (24 mg/mL) prior to a high-fat meal. Following placebo delivery, participants were separated into low-fat and high-fat consumers based on the number of calories ingested from fat.

The key findings of this study were:

The orlistat mouth rinse reduced total and fat calories taken during the high-fat meal in high-fat consumers but had no effect on low-fat consumers (P 0.05).

Orlistat reduces long-chain fatty acid (LCFA) absorption by blocking the lipases that break down lipids. Orlistat mouth rinse reduced fat intake in high-fat consumers, indicating that orlistat prevented LCFA detection from the high-fat test meal. Orlistat delivered orally is expected to reduce the risk of oil incontinence and also enhance weight loss in people who prefer fat based food.

Reference: 

Primeaux, S. D., Dubin, R., & Greenway, F. L. (2023). Orlistat mouth rinse: Using the tongue to deliver antiobesity medication in a double‐blind randomized crossover pilot trial. In Diabetes, Obesity and Metabolism. Wiley. https://doi.org/10.1111/dom.15101


Tags:    
Article Source : Diabetes Obesity and Metabolism

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News